The secreted signalling molecule *Sonic hedgehog* (*Shh*) acts to specify positional identities and to promote cell proliferation and survival in a wide range of organ systems[@b1][@b2][@b3][@b4][@b5]. In the vertebrate limb and brain, for example, Shh has been proposed to integrate patterning with growth, and in both systems removal of Shh leads to altered pattern formation because of diminished proliferation of progenitor cells[@b6][@b7][@b8]. Although the Shh pathway can regulate expression of genes that control the cell cycle, including G1/S cyclins[@b4][@b5][@b6], the cellular mechanisms by which Shh influences proliferation are not well understood. Moreover, data from multiple systems suggest varied and context-specific roles for Shh in control of the cell cycle[@b5].

During external genital development, a pair of swellings arises from the anterior margin of the cloaca and forms the genital tubercle, the embryonic precursor of the penis and clitoris, which then undergoes a sustained period of proximodistal outgrowth. Growth of the tubercle is coordinated with three dimensional tissue patterning and urethral tubulogenesis. Transcription of *Shh* begins before the initiation of genital budding in a lineage-restricted compartment of cloacal endoderm that gives rise to the urethral epithelium, and *Shh* expression persists through the early stages of sexual differentiation[@b9][@b10]. In Shh knocknot mice[@b11], loss of *Shh* results in complete absence of external genitalia, and although mutant embryos initiate genital budding, outgrowth arrests before the formation of a genital tubercle[@b9][@b12][@b13]. Recent studies demonstrated that disruption of Shh signalling after initiation of the tubercle results in truncation of the phallus[@b14][@b15][@b16], which raises new questions about the cellular mechanisms by which Shh integrates organ growth and pattern formation.

To address the cellular and molecular mechanisms by which Shh regulates genital outgrowth, we conducted temporally controlled, tissue-specific deletions of Shh at different stages of external genital development. We find that very early, transient expression of Shh is sufficient to specify the normal spatial patterns of gene expression in the genital tubercle; however, prolonged Shh activity is required for this pattern to be expanded. Disruption of Shh signalling results in a sustained decrease in the expression of cell cycle regulatory genes that govern the G1/S transition, as well as a transient downregulation of G2/M promoting genes. Analysis of cell cycle kinetics after Shh inactivation shows that the duration of the cell cycle is increased from 8.5 to 14.4 h, and this is due to an increase in the length of G1. Consequently, fewer progenitor cells enter S-phase, which slows the rate of genital tubercle growth. We conclude that Shh controls the rate of progenitor cell proliferation, and thus progenitor pool size, by regulating the speed of the cell cycle in the genital tubercle. The finding that cell cycle regulatory genes in the limb buds and genital tubercles show similar responses to Shh inactivation suggests that regulation of cell cycle kinetics by Shh may be a fundamental aspect of appendage development.

Results
=======

Transient Shh activity specifies pattern but growth is reduced
--------------------------------------------------------------

During external genital development, *Shh*-expressing cells are confined to the endoderm and signal to the surrounding mesoderm and ectoderm ([Fig. 1a](#f1){ref-type="fig"} and study by Seifert *et al*.[@b10]). We inactivated *Shh* after the initiation of genital budding using a tamoxifen-inducible cre (*Shh*^*creERT2*^) to delete a floxed allele of *Shh* (*Shh*^*C*^) in *Shh*^*creERT2/C*^ embryos[@b17][@b18]. To determine the time required for tamoxifen to activate cre and induce recombination, we monitored *LacZ* expression from the *Rosa26* reporter (*R26R*) allele, which is induced in response to cre recombinase[@b19]. *LacZ* was first detectable 6 h after tamoxifen injection, with strong reporter activity observed in all sites of endogenous *Shh* expression 9 h after injection ([Fig. 1b](#f1){ref-type="fig"}). We then identified when Shh signal transduction was terminated by monitoring expression of *Ptch1*, a transcriptional readout of the Shh effector genes, *Gli1* and *Gli2*. *Ptch1* transcripts were detected at low levels in the genitalia 12 h after tamoxifen injection, but were undetectable at 24, 48 and 72 h after injection, demonstrating complete and irreversible inactivation of Shh signalling by 24 h ([Fig. 1c](#f1){ref-type="fig"}). The extent of genital tubercle outgrowth in these mutants is correlated with the duration of Shh signalling, with longer Shh exposures leading to more extensive outgrowth ([Fig. 1d](#f1){ref-type="fig"}).

To determine whether early removal of Shh affects the establishment of positional identity in the genital tubercle, we deleted Shh immediately after the emergence of the genital tubercle and examined the expression patterns of genes that mark specific positions of the tubercle and are required for external genital development. *Wnt5a, Hoxd13* and *Hoxa13* are expressed throughout the tubercle and are required for outgrowth[@b20][@b21][@b22]. *Bmp4, Bmp7* and *Msx2* mark dorsal, ventral and distal sides of the genital tubercle and regulate several aspects of genital morphogenesis[@b9][@b12][@b23][@b24]. Surprisingly, when the Shh pathway was inactivated as early as E11.5, although the tubercles were reduced in size, normal spatial expression of *Wnt5a*, *Hoxd13* and *Hoxa13* was maintained at E13.5 ([Fig. 2a](#f2){ref-type="fig"}). *Bmp4, Bmp7* and *Msx2* were also maintained in appropriate spatial positions 24 and 48 h after the loss of Shh signalling, although the paired lateral domains of *Bmp* expression, which correspond to cells of the preputial glands in wild-type mice, were not detected in Shh conditional mutants ([Fig. 2b](#f2){ref-type="fig"}, [Supplementary Fig. S1](#S1){ref-type="supplementary-material"}). Taken together, these results indicate that the molecular polarity of the tubercle is maintained in the absence of Shh signalling, demonstrating that only transient exposure to *Shh* is required to establish the normal spatial patterns of gene expression.

Although spatial domains of gene expression appeared normal in *Shh*^*creERT2/C*^ mutant embryos, patterning defects could result from diminished levels of transcriptional activity. We therefore deleted *Shh* and quantified gene expression levels 48 h after tamoxifen injection. When *Shh* was inactivated by an E10.5 injection, only *Msx2* showed a significant decrease ([Fig. 2c](#f2){ref-type="fig"}). This was initially surprising, given that *Msx2* is regulated by Bmp4 and Bmp7 in limb buds, however, in the early genital tubercle *Msx2* and *Bmp4/7* show little (if any) overlap, suggesting the presence of other Shh-dependent regulators of *Msx2* at this stage. Deletion of *Shh* by an E11.5 injection resulted in small but significant decrease in *Msx2* as well as *Bmp4* and *Bmp7* ([Fig. 2b,d](#f2){ref-type="fig"} and [Supplementary Fig. S1](#S1){ref-type="supplementary-material"}). The quantitative reduction in *Bmp4* and *Bmp7* levels at E13.5 most likely reflects downregulation in two areas that normally express *Shh*; mutants show decreased signal in and around the urethral plate ([Fig. 2b](#f2){ref-type="fig"} and [Supplementary Fig. S1](#S1){ref-type="supplementary-material"}), and absence of signal where the preputial glands normally form ([Fig. 2b](#f2){ref-type="fig"}). Loss of gene expression in the preputial glands correlated with ventral hypoplasia of the prepuce, which normally surrounds the tubercle, suggesting that preputial development might be partly governed by Shh. Collectively, the spatial expression patterns observed by *in situ* hybridization and the quantitative levels of expression detected by quantitative reverse transcription--polymerase chain reaction (qRT--PCR) suggest that transient Shh activity at the initiation of outgrowth is sufficient for the normal pattern specification in the genital tubercle, but that sustained Shh activity is required for transcription to be maintained at appropriate levels.

Shh controls cell number and expression of cell cycle genes
-----------------------------------------------------------

Once a molecular pre-pattern has been established in a developing organ, elaboration of the pattern requires extensive growth. To dissect the role of Shh in the expansion of genital tubercle progenitor cells, we quantified genital tubercle volume and total cell number in *Shh*^*creERT2/C*^ mutant and control embryos ([Fig. 3a--f](#f3){ref-type="fig"}). Twenty-four hours after inactivation of Shh signalling, genital tubercle volume and total cell number were decreased by ∼75% (*t*~(4)~=3.64, *P*=0.01 and *t*~(4)~=2.92, *P*=0.02 respectively; [Fig. 3b--e](#f3){ref-type="fig"}). Neither cell death nor cell density differed significantly (for density, *t*~(4)~=1.33, *P*=0.12; [Fig. 3f](#f3){ref-type="fig"} and [Supplementary Fig. S2](#S1){ref-type="supplementary-material"}), indicating that the reduction in progenitor cell number was not due to dying cells. To test the hypothesis that the growth deficiency reflected a disruption of cell proliferation, we first searched for Shh target genes that could mediate its mitogenic effects. The transcription factors *Foxf1* and *Foxf2*, which have been implicated in Shh-mediated control of the cell cycle[@b25][@b26], were downregulated within 24 h of Shh inactivation ([Supplementary Fig. S3](#S1){ref-type="supplementary-material"}). We next used the quantitative RT^2^--PCR Profiler Array to monitor the response of 84 genes involved in cell cycle regulation, and compared *Shh*^*creERT2/C*^ mutant and control genitalia at different time points after inactivation of Shh ([Fig. 4a,b](#f4){ref-type="fig"}). Examination of cell cycle genes 24 h after tamoxifen injection revealed significant reductions in the levels of cell cycle control genes that control both the G1/S transition (*Cyclin E1, Dp1*) and G2/M-phase progression (*Cyclin B1*, *Cdc25a*; [Fig. 4a,b](#f4){ref-type="fig"}). *Cyclin E1*, *Dp1* and the *Dp* binding partner *E2f1* remained significantly reduced for at least 24 h after Shh inactivation, suggesting a sustained disruption in G1 progression ([Fig. 4a,b](#f4){ref-type="fig"}). *Myc* levels also decreased (see below and [Fig. 4c](#f4){ref-type="fig"}) but three Cdk inhibitors, *Cdkn1a, Cdkn1b* and *Cdkn2a*, did not change significantly (*P*=0.64, 0.959 and 0.492, respectively). We also observed a significant decrease in the S-phase promoting gene *Cyclin A1* and a small but significant decrease in the helicase components *Mcm2* and *Mcm3*, which are involved in DNA replication ([Fig. 4a,b](#f4){ref-type="fig"}). These results show that loss of Shh causes a transient downregulation of G2/M promoting genes and a sustained decrease in the expression of genes that govern the G1/S transition. Our discovery that Shh regulates expression of *Myc*, *Rb1*, *Dp1* and *E2f1* suggests a novel mechanism by which Shh can exercise fine-scale control of cyclin levels through control of cyclin modifiers.

Cell cycle gene regulation is conserved in limbs and genitalia
--------------------------------------------------------------

*Cyclin D1,* which has been reported to be a target of Shh signalling in other contexts[@b6][@b27][@b28], showed no significant differences between *Shh*^*creERT2/C*^ mutant and control genitalia by two independent quantitative analyses (qRT--PCR, *P*=0.743;. RT^2^ Profiler Array, *P*=0.251). This led us to investigate whether the Shh pathway acts on different cell cycle regulators in different tissues. We compared E12.5 limb buds and genital tubercles in which Shh had been inactivated at E11.5 (by tamoxifen injection 24 h earlier), when Shh is expressed in both structures. qRT--PCR analysis showed that, as in the genital tubercle, mutant and control limb buds at E12.5 showed no significant difference in *Cyclin D1* expression levels (*P*=0.788). However, the limb buds and genital tubercles undergo significant decreases in *E2f1, Dp1* and *Myc* expression, and significant increases in expression of *Rb1*, a negative regulator of S-phase entry ([Fig. 4c](#f4){ref-type="fig"}). Given that Rb1 binds and inactivates E2f1 (study by Rubin *et al*.[@b29]), the consequence of decreased levels of *E2f1* and increased levels of *Rb1* would be an even further reduction of E2f1 activity during the G1--S transition, both in the genital tubercle and limb bud. These findings show that Shh can control the same cell cycle regulators in different tissues, suggesting that conserved mechanisms may mediate the ability of Shh to regulate outgrowth of different types of appendages.

Cell cycle kinetics are disrupted by Shh inactivation
-----------------------------------------------------

The finding that Shh controls quantitative levels of expression of multiple cell cycle regulators raised the possibility that the growth deficiency of *Shh*^*creERT2/C*^ genitalia could be caused by disruption of the cell cycle. Given that genital outgrowth slows but does not arrest after Shh inactivation, we tested the hypothesis that Shh may regulate the rate of genital outgrowth by regulating the kinetics of the cell cycle[@b8]. Cell proliferation kinetics were examined quantitatively by calculating the proportion of cells in different phases of the cell cycle in the genitalia of *Shh*^*creERT2/C*^ embryos. To label cells in S-phase, bromodeoxyuridine (BrdU) was injected 20 h after inactivation of the Shh pathway and embryos were allowed to develop *in utero* for 4 h to allow sufficient time for BrdU-labelled cells to transition from S-phase to G2/M-phase. Embryos were then harvested and labelled with antibodies against BrdU and phosphorylated Histone H3 (PHH3), a marker for cells in G2/M-phase[@b30]. We calculated the proportion of mesenchymal cells that were labelled with BrdU alone (S-phase), PHH3 alone (G2/M-phase), double labelled with BrdU and PHH3 (S-phase cells that had moved into G2/M-phase within 4 h) or were unlabelled (G0/G1) ([Fig. 5](#f5){ref-type="fig"}; see [Methods](#an1){ref-type="sec"} section). An analysis of variance revealed differences in the proportion of cells in S-phase, G2/M-phase and G0/G1 in *Shh*^*creERT2/C*^ mutant versus *Shh*^*+/C*^ littermates that approached significance (F~(2,8)~=4; *P*=0.06). Planned comparisons of the proportion of cells in S-phase, G2/M-phase and G0/G1 phase indicated that *Shh*^*creERT2/C*^ mutant animals (*n*=3) had an 8% decrease in S-phase cells (*P*=0.03) and a 7% increase in G0/G1-phase cells (*P*=0.05) relative to *Shh*^*+/C*^ littermates (*n*=3; [Fig. 5a](#f5){ref-type="fig"}). The observation that *Shh*^*creERT2/C*^ mutants exhibit a reduction in the number of cells in S-phase and a concomitant increase in the proportion of cells in G0/G1 is consistent with our finding that genes regulating the G1/S transition are reduced, and suggests that progression through G1 or the G1/S checkpoint is disrupted when Shh is removed.

A longer G1 phase underlies the growth defect in Shh mutants
------------------------------------------------------------

How could these relatively small proportional shifts in cell cycle phase lead to the large growth differences that result from deletion of Shh? If Shh is involved in regulating G1/S and G2/M transitions, then one possibility is that loss of Shh signalling induces cells to arrest at specific cycle checkpoints, thereby arresting proliferation or inducing apoptosis; however, such changes did not occur after deletion of Shh ([Fig. 1d](#f1){ref-type="fig"} and [Supplementary Fig. S2](#S1){ref-type="supplementary-material"}). Alternatively, inactivation of Shh could decrease the rate of progression through G1, which would be reflected by increased cycle length. To calculate cell cycle kinetics of progenitor cells in the developing genital tubercle mesenchyme, we applied the principles developed by Nowakowski *et al*.[@b31] for quantification of cell cycle length. The relative lengths of S-phase (T~S~) and the entire cell cycle (T~c~) were determined for both *Shh*^*creERT2/C*^ (*n*=3) and wild-type littermates (*n*=3) by measuring the proportions of cells in S-phase (BrdU/4,6-diamidino-2-phenylindole (DAPI) positive), S-phase cells that have cycled through G2/M (BrdU/PHH3/DAPI positive) and unlabelled cells (DAPI positive; see formulas in [Fig. 5d](#f5){ref-type="fig"} and labelled cells in [Fig. 5e--i](#f5){ref-type="fig"}). Inactivation of Shh signalling at E11.5 resulted in lengthening of the entire cell cycle (T~c~) from 8.5 to 14.4 h (*t*~(4)~=2.83; *P*=0.024) ([Fig. 5b](#f5){ref-type="fig"}). BrdU analysis revealed a greater proportion of unlabelled cells in *Shh*^*creERT2/C*^ mutants (*t*~(4)~=1.62; *P*=0.09), suggesting that this lengthening is not a result of altered S-phase duration but more likely reflects a delay in G1 or the G1/S checkpoint ([Fig. 5b](#f5){ref-type="fig"}). Such a marked increase in cell cycle duration would be expected to reduce the total cell number, which may account for the ∼75% reduction of tubercle volume in *Shh*^*creERT2/C*^ mutants. Indeed, when the proportion of cells in each phase of the cell cycle is weighed against total cell number, the data show that the loss of Shh signalling decreases the cycling cell population by ∼73% ([Fig. 5c](#f5){ref-type="fig"}). Thus, loss of Shh activity lengthens the time that cells spend in G1/G0, thereby reducing the number of cells in S-phase, which, in turn, feeds fewer cells into G2/M-phase and, ultimately, back into the cell cycle ([Fig. 6](#f6){ref-type="fig"}). Taken together, these data indicate that Shh controls the rate of progenitor cell proliferation, and thus progenitor pool size, by regulating the speed of the cell cycle. This highlights a novel mechanism for Shh-mediated control of organ growth.

Discussion
==========

These studies demonstrate that transcriptional levels of genes that control the G1/S transition are quantitatively regulated by the Shh pathway during external genital and limb outgrowth. This extends previous *in vitro* studies that showed that Shh and its downstream effectors can interact with specific cell cycle proteins to drive both growth phases of the cell cycle[@b4][@b5][@b6][@b8][@b32]. Our finding that Shh activity determines the level of *Dp1* and its *E2f* binding partners, which are activators of *Cyclin E* and *A1*, may account for the reduced Cyclin levels in Shh mutant embryos. *Cyclin E* and *A1* expression may be further refined by Shh through the increased negative regulation of *Rb1*, which limits E2f1 activity. Although hedgehog gain-of-function studies have suggested a role for *Cyclin D1* in Shh-mediated control of cell proliferation, our quantitative analysis showed minimal changes in *Cyclin D1* levels in mouse limbs and genitalia after the loss of Shh, which is consistent with results from the chick limb[@b6]. Taken together, these data reveal new molecular mechanisms for Shh-mediated regulation of cell cycle length, specifically the duration of G1 and the G1/S transition, and highlight how subtle changes in the kinetics of the cell cycle are amplified over developmental time to alter morphological pattern.

On the basis of these results, we suggest that after the early pattern is specified in the genital tubercle, Shh promotes its elaboration and growth by regulating the length of the cell cycle ([Fig. 6](#f6){ref-type="fig"}). The control mechanism identified here may also operate in other signalling pathways and has implications for other developing organs. In the limb, for example, two recent studies reported that Shh specifies digit identity at early stages and that sustained expression is required for proliferation of progenitor cells and normal elaboration of skeletal pattern[@b6][@b7]. Both studies reported changes in the proportion of cells in different phases of the cell cycle, although how such changes can lead to a reduction of organ growth is not well understood at the cellular level. In light of our finding that Shh signalling determines the length of specific cell cycle phases, and that Shh regulates the same cell cycle control genes in the genital tubercle and limb bud, one possibility is that the loss of digits and the proximodistal truncations associated with reduced Shh activity in the limb may be caused by temporal changes in cell cycle kinetics, similar to those observed in the genitalia.

Factors that alter cell cycle rates during the development can influence the morphology and size of an organ, and this may reflect the extent to which the early pattern has been amplified during growth[@b33]. Shh-mediated modulation of cell cycle duration may also underlie heterochronic changes during morphological evolution. For example, temporal truncation of *Shh* expression in the limb bud is associated with decreased proliferation and reduction of digit number in skinks[@b34]. Our results predict that such a reduction of Shh activity would lengthen cell cycle duration and thereby decrease the progenitor cell population in the limb. Similarly, the ability of hedgehog to alter cell cycle length may influence the rate of tumour growth in hedgehog pathway-mediated cancers[@b35]. Thus, these findings highlight the potential for modulators of cell cycle length to result in phenotypic changes in development, disease and evolution.

Methods {#an1}
=======

Animals
-------

The *Shh*^*GFPcre*^,*Shh*^*creERT2*^, *Shh*^*C*^ and *R26R* alleles have been described elsewhere[@b17][@b18][@b19]. Tamoxifen (3 mg dissolved in corn oil) was administered to pregnant females at E10.5, E11.5 and E12.5 to induce cre-mediated deletion of *Shh*^*C*^. BrdU (100 mg per kg) was injected 44 h after tamoxifen to label cells in the S-phase of mitosis, and pups were collected 4 h later for analysis of cell cycle kinetics. All animal experiments were performed in accordance with institutional guidelines.

Immunohistochemistry
--------------------

Tissue was incubated in rat anti-BrdU (1:500; Accurate) and mouse anti-phosphorylated Histone-H3 (1:500; Upstate) overnight at 4 °C and then in the minimally cross-reactive secondary donkey anti-rat Cy3 and donkey anti-mouse Cy5 (1:500, Jackson Immunoresearch) antibodies overnight at 4 °C. The tissue was washed repeatedly between steps with tris-buffered saline. Live embryos were immersed in Lysotracker Red (1:5,000; Molecular Probes) at 37 °C for 30 min to label regions of cell death, then washed in phosphate-buffered saline and dehydrated in methanol for imaging.

*In situ* hybridization
-----------------------

Whole mount *in situ* hybridization was conducted according to published methods[@b9] using digoxigenin-lablelled riboprobes for *Shh* (kindly provided by A. McMahon)*, Wnt5a* (A. McMahon), *Ptch1* (M. Scott) *Hoxd13* (D. Duboule)*, Hoxa13* (S. Stadler), *Bmp4* (B. Hogan)*, Bmp7* (B. Hogan), *Msx2* (R. Hill), *FoxF1* (P. Carlsson) and *FoxF2* (P. Carlsson).

Quantitative RT--PCR
--------------------

*Shh*^*creERT2/C*^ and control (*Shh*^*+/c*^) mice were collected from the same litters of tamoxifen-treated mothers. Genital tubercles were dissected from stage-matched embryos and were pooled according to genotype for each litter collected. RNA was extracted using Trizol. After treatment with RNase-free DNase I (Ambion), three pooled samples for each genotype were purified using the RNeasy Mini kit (Qiagen). RNA quantity and purity were determined using a NanoDrop ND-1000, and RNA integrity was assessed by determining the RNA integrity number and 28S/18S ratio using a Bioanalyzer 2100 (Agilent Technologies). A quantity of 500 ng of high-quality RNA (260/280 ratios slightly higher than 2.0 and 260/230 ratios higher than 1.7, RIN\>8.0) for each pooled sample was converted into cDNA using the RT^2^ First Strand cDNA Kit (SABiosciences). All qPCR reactions use the RT^2^ SYBR Green qPCR Master Mix (SABiosciences). Cell cycle gene expression was determined using Cell Cycle PCR Array (PAMM-020, SABiosciences) and the My iQ5 system (Bio-Rad) according to the manufacturer\'s protocol. All significant changes in gene expression levels are reported in the article; the complete list of genes assayed on the array can be found at the manufacturer\'s website (http://www.sabioscience.com/rt_pcr_product/HTML/PAMM-020A.html). For patterning genes and additional cell cycle genes, expression was detected using the My iQ5 QPCR system (Bio-Rad) with Actb and Gapdh[@b36] as controls. Primers not previously published were designed using Beacon Designer Software (except for Actb, which was purchased from http://www.realtimeprimers.com). The qRT--PCR primers designed for this study are listed in [Table 1](#t1){ref-type="table"}.

Stereological estimates of total cell numbers
---------------------------------------------

Total (DAPI-labelled), S-phase (BrdU-labelled), S- and G2/M-transition phase (BrdU/PHH3) and G2/M-phase (PHH3) cells were estimated stereologically using the optical fractionator method by counting target cells on every 12th midsagittal section (∼6 sections through the entire mediolateral axis of mesenchyme in both *Shh*^*creERT2/C*^ mutants and control littermates), following published methods for counting cells through irregularly shaped structures, such as brain regions or kidneys[@b37][@b38]. Briefly, cells of interest were counted on images acquired using a ×10 objective, N.A. 0.3 on an AxioObserver Microscope and AxioVision Software (version 4.1; Zeiss). Section thickness was confirmed to be ∼12 μm by focusing through the sample. Cells that fell within the 45×45 μm counting frame (in a sampling grid of 235×235 μm) were used in the analyses. To estimate total mesenchymal volume, the area of mesenchyme on each section was traced and quantified using AxioVision software and the total volume of the structure was estimated using Cavalieri\'s principle[@b37]. Densities were determined by dividing the number of cells in the region of interest by the area in which the cells were counted (that is, 45×45 μm). Proportions of cells were calculated by counting total cells (DAPI-labelled) and S-phase cells (BrdU-labelled) in five separate counting frames per section, and G2/M-transition phase (BrdU/PHH3) and G2/M-phase (PHH3) cells were counted on the entire section. This was performed to avoid subsampling errors due to the low number of PHH3-positive cells per section.

Cell cycle kinetics
-------------------

Females were injected with tamoxifen and BrdU as described in the text. S-phase and total cell cycle length were calculated according to equations in [Figure 5](#f5){ref-type="fig"}. BrdU labels cells approximately 30 min after injection[@b39][@b40] and is metabolized in approximately 2 h,[@b31][@b39]. Given that S-phase in both mouse and chick mesenchyme (paraxial and lateral plate) *in vivo* is at least 3 h[@b41][@b42], a 4-h interval between injection and collection was chosen to allow BrdU-labelled mesenchymal cells to transition from S-phase to G2/M-phase. Although this may result in slight under-representation of cells that transitioned from G1- to S-phase after BrdU metabolism, and cells in late S-phase would be BrdU positive in early G2, on the basis of the relative nature of the proportion calculations, the percentages reported for each phase are accurate using this labelling scheme.

Statistical analysis
--------------------

All group differences in our dependent variables were revealed using Student\'s *t*-tests (one dependent variable between groups) or analysis of variances (more than one dependent variable between groups) and explored using Newman--Kewls *post hoc* tests. *α*-Levels were set at 0.05.

Volumetric measures
-------------------

Tubercle mesenchyme volume differences between *Shh*^*creERT2/C*^ and wild-type littermates were determined using Cavalieri\'s principle[@b37]. Total cell numbers were estimated for G1/G0 (DAPI positive), S-Phase (BrdU positive) and G2/M-phase (BrdU/PHH3 positive cells) using the optical fractionator principle on every 12th section through the structure (∼6 sections per animal)[@b37]. Proportions and densities of cells were also calculated in different phases of the cell cycle.
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![Temporal inactivation of Shh signalling in the external genitalia.\
(**a**) Lateral view of X-gal-stained *Shh*^*GFPcre*^*; R26R* mouse embryo at E12.5 showing position of *LacZ* expression in *Shh*^*GFPcre*^ descendent cells. Image captured using optical projection tomography. Red box shows schematic of a transverse section through the external genitalia at the level of the hindlimbs and depicts the position of Shh-producing cells at the posterior end of the embryo. (**b**) *LacZ* expression (red arrows) in *Shh*^*creERT2*^*;R26R* embryos collected 6 and 9 h after injection of pregnant dams with tamoxifen. (**c**) Comparison of *Ptch1* expression in *Shh*^*creERT2/C*^ and *Shh*^*+/C*^ embryos 24 and 48 h after tamoxifen injection. (**d**) Range of anogenital phenotypes produced by loss of Shh function at different developmental stages. All mice are males. Left panel shows complete agenesis of external genitalia and persistence of cloaca in *Shh*^*−/−*^ mutant. Middle panels show anogenital regions of *Shh*^*creERT2/C*^ mice, in which *Shh* was inactivated at E11.5 and E13.5 (tamoxifen injection at E10.5 and E12.5, respectively). Right panel shows normal genitalia of wild-type mouse with normal Shh activity.](ncomms1020-f1){#f1}

![Early and transient Shh expression is sufficient for pattern specification in the genital tubercle.\
(**a**, **b**) Whole mount *in situ* hybridizations showing gene expression patterns in genital tubercles of *Shh*^*creERT2/C*^ and control *Shh*^*+/c*^ mice. Genital tubercles are shown in ventral view, except where indicated. *Shh* was inactivated by tamoxifen injection at E10.5, immediately after initiation of tubercle outgrowth, and embryos were collected at E12.5 (*Bmp4,* and *Msx2*) or E13.5 (*Wnt5a, Hoxd13, Hoxa13, Bmp7*). Genital tubercles are reduced in size but show normal spatial expression patterns except for absence of *Bmp7* expression in preputial glands (red arrow in **b**). Black arrows mark regionalized gene expression domains. Enlargement (red box) shows *Bmp7*-expressing preputial gland cells in control littermate. (**c**, **d**) qRT--PCR data for genes shown in (**a**) and (**b**). Embryos were injected with tamoxifen at E10.5 and collected at E12.5 (**c**), and injected at E11.5 and collected at E13.5 (**d**). Transcript levels expressed as percentage relative to control littermates, with *n*=3 for each data point. Error bars show ± s.e.m. and asterisks denote significant differences in (**c**) *Msx2* (*P*=0.009) and (**d**) *Msx2* (*P*=0.013), *Bmp4* (*P*=0.002) and *Bmp7* (*P*=0.010).](ncomms1020-f2){#f2}

![Stereological estimates reveal decreased cell number in Shh-depleted genitalia.\
(**a**--**c**) Genital tubercles of *Shh*^*creERT2/C*^ and control *Shh*^*+/c*^ embryos are shown at E12.5. Pregnant females were injected with tamoxifen at E10.5 and with BrdU 44 h later. (**a**) Lateral view of E12.5 *Shh*^*GFPcre*^*;R26R* embryo stained with X-Gal to show *Shh*-expressing cells[@b10]. Red box marks region of genital tubercle (gt) and underlying cloacal endoderm shown in (**b**) and (**c**). (**b**, **c**) Control *Shh*^*+/C*^ (**b**) and *Shh*^*creERT2/C*^ (**c**) embryos at ×10 magnification showing BrdU-labelled cells (red). (**d**--**f**) Estimates of volume (**d**) total mesenchymal cell number (**e**) and cell density (**f**) in *Shh*^*creERT2/C*^ (white bars; *n*=3) and control *Shh*^*+/c*^ (black bars; *n*=3) embryos. Data represented as means with ± s.e.m. \**P*\<0.05.](ncomms1020-f3){#f3}

![Shh inactivation alters cell cycle gene expression in genital tubercles and limb buds.\
(**a**, **b**) Quantitative comparison of transcript levels in *Shh*^*creERT2/C*^ and *Shh*^*+/c*^ embryos assayed at three time points (indicated in key) using the RT^2^-Profiler PCR Array (SABiosciences). Tamoxifen injections were administered at E10.5 and E11.5. Changes in transcript level are expressed as percent change relative to control embryos for G/S-phase cell cycle genes (**a**) and S- and G2/M-phase genes (**b**). Error bars show ± s.e.m., *n* = 3 and asterisks denote significant differences for E11.5 injection/E12.5 collection (*Cyclin E1, P*=0.030; *Dp1, P*=0.055; *Cyclin B1, P*=0.019; *Cdc25a, P*=0.034; *Mcm3, P*=0.031), E10.5 injection/E12.5 collection (*Cyclin A1, P*=0.011; *E2f1, P*=0.013), E11.5 injection/E13.5 collection (*Cyclin A1, P*=0.0004; *Cyclin E1, P*=0.027; *Dp1, P*=0.033; *E2f1, P*=0.010; *Mcm2, P*=0.052). (**c**) Graph shows comparison of transcript levels in limb buds (grey bars) and genital tubercles (black bars) of *Shh*^*creERT2/C*^ relative to *Shh*^*+/C*^ embryos. Tamoxifen injections were administered at E10.5 and embryos were collected for qRT--PCR at E12.5. Changes in transcript level are expressed as percent change relative to control embryos. Error bars show ± s.e.m., *n* = 3 and asterisks denote significant differences in *E2f1* (GT, *P*=0.010; limb, *P*=0.008), *Dp1* (GT, *P*=0.012; limb, *P*=0.026), *Myc* (GT, *P*=0.034; limb, *P*=0.039) and *Rb1* (GT, *P*=0.040; limb, *P*=0.040).](ncomms1020-f4){#f4}

![Shh controls growth of the genital tubercle by regulating cell cycle kinetics.\
(**a**) Proportion of cells in each phase of the cell cycle. Labelling scheme groups G2 and M. Error bars show s.e.m., *n* = 3, \* *P*\<0.05. (**b**) Estimated cell cycle times for *Shh*^*creERT2/C*^ (mutant) and *Shh*^*+/c*^ (control) embryos. Means are shown for mutant and control embryos and s.e. of the mean is provided for T~c~. (**c**) Total cell number calculated for each phase of the cell cycle at E12.5. Error bars show s.e.m., *n* = 3. (**d**) Summary of cell labelling scheme used to determine lengths of S-phase (T~s~) and total cell cycle (T~c~). The red arcs refer to cell population labelled with BrdU, the blue arc refers to cell population labelled with phosphohistone-H3, and green arc refers to cell population labelled with only DAPI (arc lengths not to scale). (**e**) Sagittal section through genital tubercle of *Shh*^*C/+*^ embryo at E12.5 shown at ×10 magnification. White box depicts area of counting frame used for cell counts. (**f**--**i**) High magnification (×145), single channel (**f**--**h**) and merged (**i**) exposures of boxed area in (**e**) showing cells labelled with DAPI (white, panel **f**) BrdU (red, panel **g**), phosphohistone-H3 (green, panel **h**). Yellow arrowheads mark examples of cells positive for both PHH3 and BrdU, and the white arrowhead marks a cell positive for BrdU but negative for PHH3.](ncomms1020-f5){#f5}

![A model for *Shh*-mediated integration of growth and patterning.\
Shh activity in wild-type (WT) and *Shh*^*creERT2/C*^ (mutant) genital tubercles is shown in top panel, and is based on analysis of *Ptch1* expression (see [Fig. 1c](#f1){ref-type="fig"}). During outgrowth of the genital tubercle, cell populations (red, tan, black coloured circles) defined by regionalized gene expression are exposed to secreted Shh (blue shaded areas). In wild-type genitalia, these cells divide approximately every 8.5 h and, as these progenitor pools double in number, this expands gene expression patterns. Following loss of Shh activity in mutant genitalia, cells continue to divide but cell cycle length increases to 14.4 h. This leads to a reduction in both the doubling rate of progenitor pools and the overall size of the genital tubercle. The general molecular pattern of the mutant tubercle is retained. Large red circles above and below tubercles represent the doubling time of all cells in the genital tubercle. T~c~, total cell cycle time.](ncomms1020-f6){#f6}

###### qRT--PCR primer sequences.

  **Primer**   **Sequence**                 **Sequence source**
  ------------ ---------------------------- --------------------------------
  Msx2 Fwd     CGTGTTGGGCAGATGGAGAAG        GenBank accession \# 013601
  Msx2 Rev     AGAGATGGACAGGAAGGTGAGAC       
  Bmp4 Fwd     GAACAGGGCTTCCACCGTATAAAC     GenBank accession \# 007554
  Bmp4 Rev     TGTCCAGTAGTCGTGTGATGAGG       
  Bmp7 Fwd     TCTTCCTGAGACCCTGACCTTTG      GenBank accession \# 007557
  Bmp7 Rev     TGGGCAGTGAGAGACTTAGATGG       
  Ccnd1 Fwd    GCGTACCCTGACACCAATCT         GenBank accession \# 007631
  Ccnd1 Rev    CTCTTCGCACTTCTGCTCCT          
  Rb1 Fwd      GCAAGTTGATTGACTGTCCACATTC    GenBank accession \# 009029
  Rb1 Rev      AAACAAACACACGGCACATTAGATTC    
  E2f1 Fwd     GGAAAGGGAGAGGGAGACAGAC       GenBank accession \# 007891
  E2f1 Rev     AGCCATAGGAAGGACGCATACC        
  Tfdp1 Fwd    TGAGAACGACGAGGAGGATTGATTAC   GenBank accession \# 009361
  Tfdp1 Rev    CACGCTGGCTTCACAACACATC        
  Actb Fwd     AAGAGCTATGAGCTGCCTGA         http://www.Realtimeprimers.com
  Actb Rev     TACGGATGTCAACGTCACAC          
